[Significance of the synchronization of the leukemic cell population in the therapy of patients with acute leukemia].
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D001853:Bone Marrow; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D015122:Mercaptopurine / Q000008:administration & dosage / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use; D008938:Mitosis; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use*
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine; D014750:Vincristine; D011239:Prednisolone; D015122:Mercaptopurine; D008727:Methotrexate
K voprosu o znachenii sinkhronizatsii kletochnoĭ leĭkoznoĭ populiatsii v terapii bol'nykh ostrym leĭkozom